STOCK TITAN

Usana Health Sciences Inc - USNA STOCK NEWS

Welcome to our dedicated page for Usana Health Sciences news (Ticker: USNA), a resource for investors and traders seeking the latest updates and insights on Usana Health Sciences stock.

USANA Health Sciences Inc. (NYSE: USNA) delivers science-backed nutritional supplements and personal care products through a global direct selling network. This page provides investors and industry observers with centralized access to official company announcements and market-moving developments.

Track USANA's latest press releases including quarterly financial results, product innovation announcements, executive leadership updates, and operational expansions. Our curated feed ensures timely access to filings, partnership disclosures, and strategic initiatives that shape the company's position in the health and wellness sector.

Key focus areas include regulatory milestones for nutritional products, market entry strategies in new regions, and advancements in manufacturing quality standards. All content is sourced directly from verified corporate communications to maintain accuracy and compliance with financial disclosure standards.

Bookmark this page for streamlined monitoring of USANA's business trajectory, with updates organized chronologically for efficient research. Combine this resource with Stock Titan's financial analysis tools for comprehensive investment decision support.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
none
-
Rhea-AI Summary
USANA receives seal of approval from ConsumerLab.com for its CellSentials cellular nutrition system
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.97%
Tags
none
Rhea-AI Summary
USANA partners with Good Deed Revolution for Promise2Live campaign to address global mental health crisis
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.65%
Tags
partnership
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.27%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.99%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.68%
Tags
none
-
Rhea-AI Summary
USANA Health Sciences plans to expand into India in the second half of 2023, increasing its global footprint to 25 markets. The company believes its products and business model are well-suited for India and expects the new market to contribute modestly to sales in fiscal 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
none
Rhea-AI Summary

USANA Health Sciences, Inc. (NYSE: USNA) reported financial results for the first quarter of fiscal 2023, ending April 1, 2023. Net sales reached $248 million, down 9% from $273 million in Q1 2022 but an increase of 9% from the previous quarter. Diluted earnings per share (EPS) were $0.95, a 44% increase from $0.66 in Q4 2022, though a 17% decline compared to $1.15 in Q1 2022. The company generated $13 million in operating cash flow and ended the quarter with $295 million in cash, remaining debt-free. USANA raised its fiscal 2023 guidance for net sales to $875 to $950 million and diluted EPS to $2.40 to $3.30, reflecting strong early quarter performance driven by demand in China and proactive measures like product price increases.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.45%
Tags
none
Usana Health Sciences Inc

NYSE:USNA

USNA Rankings

USNA Stock Data

449.43M
10.85M
42.19%
59.03%
4.45%
Packaged Foods
Medicinal Chemicals & Botanical Products
Link
United States
SALT LAKE CITY